Literature DB >> 24390897

The symptom cluster-based approach to individualize patient-centered treatment for major depression.

Steven Y Lin1, Michael B Stevens.   

Abstract

Unipolar major depressive disorder is a common, disabling, and costly disease that is the leading cause of ill health, early death, and suicide in the United States. Primary care doctors, in particular family physicians, are the first responders in this silent epidemic. Although more than a dozen different antidepressants in 7 distinct classes are widely used to treat depression in primary care, there is no evidence that one drug is superior to another. Comparative effectiveness studies have produced mixed results, and no specialty organization has published recommendations on how to choose antidepressants in a rational, evidence-based manner. In this article we present the theory and evidence for an individualized, patient-centered treatment model for major depression designed around a targeted symptom cluster-based approach to antidepressant selection. When using this model for healthy adults with major depressive disorder, the choice of antidepressants should be guided by the presence of 1 of 4 common symptom clusters: anxiety, fatigue, insomnia, and pain. This model was built to foster future research, provide a logical framework for teaching residents how to select antidepressants, and equip primary care doctors with a structured treatment strategy to deliver optimal patient-centered care in the management of a debilitating disease: major depressive disorder.

Entities:  

Keywords:  Behavioral Sciences; Depression; Evidence-based Medicine; Medical Decision Making; Pharmacotherapy

Mesh:

Substances:

Year:  2014        PMID: 24390897     DOI: 10.3122/jabfm.2014.01.130145

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.657


  5 in total

1.  Reevaluating the Efficacy and Predictability of Antidepressant Treatments: A Symptom Clustering Approach.

Authors:  Adam M Chekroud; Ralitza Gueorguieva; Harlan M Krumholz; Madhukar H Trivedi; John H Krystal; Gregory McCarthy
Journal:  JAMA Psychiatry       Date:  2017-04-01       Impact factor: 21.596

2.  Association between Salivary Mitochondrial DNA Copy Number and Chronic Fatigue according to Combined Symptoms in Korean Adults.

Authors:  Jinyoung Shin; Kyong Chol Kim; Duk Chul Lee; Hye Ree Lee; Jae Yong Shim
Journal:  Korean J Fam Med       Date:  2017-07-20

3.  Symptom Cluster-Matching Antidepressant Treatment: A Case Series Pilot Study.

Authors:  Sławomir Murawiec; Marek Krzystanek
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-31

4.  Effects of levomilnacipran ER on fatigue symptoms associated with major depressive disorder.

Authors:  Marlene P Freeman; Maurizio Fava; Carl Gommoll; Changzheng Chen; William M Greenberg; Adam Ruth
Journal:  Int Clin Psychopharmacol       Date:  2016-03       Impact factor: 1.659

5.  Demographic and clinical factors associated with different antidepressant treatments: a retrospective cohort study design in a UK psychiatric healthcare setting.

Authors:  Andrea C Fernandes; David Chandran; Mizanur Khondoker; Michael Dewey; Hitesh Shetty; Rina Dutta; Robert Stewart
Journal:  BMJ Open       Date:  2018-09-05       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.